Ambu AS (OTCPK:AMBFF)
$ 19.9 -0.6 (-2.93%) Market Cap: 4.15 Bil Enterprise Value: 4.24 Bil PE Ratio: 130.11 PB Ratio: 5.45 GF Score: 96/100

Q3 2022 Ambu A/S Earnings Call Transcript

Aug 25, 2022 / 07:00AM GMT
Release Date Price: $10.05 (+3.99%)
Nicolai Thomsen;S;Director of IR;Strategic Financial Planning
Ambu A

/-&

Good morning, everyone, and welcome to the conference call for Ambu's Q3 Results. I'm Nicolai Thomsen from the Investor Relations team. I'm here with our CEO, Britt Meelby Jensen; and our CFO, Thomas Frederik Schmidt.

Today's presentation can be found on our home page and there will be a Q&A session at the end of the call. And with that brief introduction, I'm very happy to hand over the word to our CEO, Britt Meelby Jensen.

Britt Meelby Jensen;S;CEO;Member of Management Board;Thomas Schmidt
Ambu A

/-&

Good morning, everyone. Hope you're well. Nice to have you on the call for this Q3 results. For those of you who may not know me, I've spent over 20 years in health care, in senior leadership positions at Novo Nordisk as CEO of DARCO, Zealand Pharma and most recently as CEO of Ates Medical. Also, I've been on the Board of Directors of Ambu for almost 3 years.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot